Calidi Biotherapeutics, Inc. — Investor Relations & Filings

Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company that develops targeted therapies for cancer. The company's proprietary technology platforms utilize allogeneic stem cells to deliver and shield oncolytic virus payloads from the patient's immune system. This approach is designed to enable the potentiation of the viral therapy, activating the immune system to destroy solid tumors and metastatic disease. Calidi's pipeline includes both systemic and localized treatments being investigated for various cancers, including a first-in-class, stem-cell-loaded viral therapy for soft tissue sarcoma which has received FDA Fast Track Designation.